Avadel Pharmaceuticals plc (AVDL) Financials
AVDL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 261.1 million | 173.4 million |
2023-09-30 | 203.1 million | 93.0 million |
2023-06-30 | 201.0 million | 57.8 million |
2023-03-31 | 140.7 million | 178.9 million |
AVDL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -28.0 million | 3.5 million |
2023-09-30 | -38.2 million | 3.1 million |
2023-06-30 | -32.0 million | 7.6 million |
2023-03-31 | -30.2 million | 1.5 million |
AVDL Net Income
No data available :(
AVDL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 105.1 million | - | 2.6 million |
2023-09-30 | 153.2 million | - | 2.8 million |
2023-06-30 | 160.5 million | - | 1.3 million |
2023-03-31 | 100.9 million | - | 1.5 million |
AVDL Shares Outstanding
AVDL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 2.4 million | 41.3 million | - |
2023-09-30 | - | 2.8 million | 39.2 million | - |
2023-06-30 | - | 4.2 million | 46.8 million | - |
2023-03-31 | - | 3.8 million | 24.5 million | - |
AVDL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 19.5 million | 693000 |
2023-09-30 | 7.0 million | 117000 |
2023-06-30 | 1.5 million | 36000 |
2023-03-31 | - | 588000 |
AVDL
Price: $18.82
52 week price:
Earnings Per Share: -2.00 USD
P/E Ratio: -6.70
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 237800
Ebitda: 27.2 millionMarket Capitalization: 1.5 billion